Prenatal growth markers in schizophrenia: a monozygotic co-twin control study

Area of Science:

• Developmental neuroscience
• Psychiatry
• Human genetics

Background:

• Schizophrenia is a complex psychiatric disorder with a significant genetic component.
• Monozygotic twins share nearly identical genes, making them valuable for studying environmental influences on disease.
• Prenatal development is increasingly recognized as a critical period for the etiology of schizophrenia.

Purpose of the Study:

• To investigate prenatal growth differences in monozygotic twins discordant for schizophrenia.
• To identify specific developmental periods associated with schizophrenia risk.

Main Methods:

• Dermatoglyphic markers, specifically a-b ridge counts, were analyzed in monozygotic twins.
• The study included discordant, concordant, and normal monozygotic twin pairs.
• Established procedures were used to obtain dermatoglyphic data.

Main Results:

• Affected twins in discordant pairs showed significantly greater a-b ridge count differences compared to their healthy co-twins.
• Schizophrenia-affected twins had fewer epidermal ridges in the right palm's a-b interdigital area.
• No significant differences were observed for developmental markers outside the 13-15 weeks gestational age window.

Conclusions:

• The findings suggest a time-specific dysgenesis during weeks 13-15 of gestation in schizophrenia-affected monozygotic twins.
• This period of altered development may represent a critical window for schizophrenia etiology.
• The study highlights potential commonalities in the developmental pathways of epidermal and neurological structures.